Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Resverlogix Corp
T.RVX
Alternate Symbol(s):
RVXCF
Healthcare
Biotechnology
Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the...
treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:RVX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(16)
•••
narmac
X
View Profile
View Bullboard History
Comment by
narmac
on Feb 01, 2022 4:50pm
RE:Sweeney & McCaffrey yesterday on CBC Radio!
Ooops,,,almost forgot,,,,It was posted on the other board by LongRVXer!!!!
(16)
•••
narmac
X
View Profile
View Bullboard History
Post by
narmac
on Feb 01, 2022 4:48pm
Sweeney & McCaffrey yesterday on CBC Radio!
https://www.cbc.ca/listen/live-radio/1-52-radio-active/clip/15892354-calgary-companys-covid-drug-going-phase-two-trials Esversana must have laid the law down!!!,,Interview was good!,,,,its a ray of
...more
(50)
•••
Georgeparros
X
View Profile
View Bullboard History
Post by
Georgeparros
on Jan 29, 2022 9:56am
Under the radar video credits to Texbraska on Agoracom
(120)
•••
ENEMENEMYNEMO
X
View Profile
View Bullboard History
Comment by
ENEMENEMYNEMO
on Jan 26, 2022 6:07pm
RE:RE:'IT WILL BE EFFECTIVE' :o()
Don't forget there is zero proof so far that apabetalone will do anything against Covid infection in a human host...there aren't even any animal studies...just some suggestions from a Petri
...more
(16)
•••
narmac
X
View Profile
View Bullboard History
Comment by
narmac
on Jan 26, 2022 10:47am
RE:'IT WILL BE EFFECTIVE' :o()
,,,trying to find the statement around the point that Apabetalone reverses the damage to organs etc from Covid 19,,,,so far this is the best I can find,,, COVID-19 affects not only lung and
...more
(16)
•••
narmac
X
View Profile
View Bullboard History
Post by
narmac
on Jan 26, 2022 9:45am
'IT WILL BE EFFECTIVE' :o()
,,Scares the begeebies out of me when DMcC makes theis claim!!,,,,,I have fingers crossed his dementia hasn't adfvanced!!!!!!!!!!!!!!!!!!!!!! In addition to reducing the duration of the disease
...more
(4)
•••
QualityTest
X
View Profile
View Bullboard History
Comment by
QualityTest
on Jan 26, 2022 12:37am
RE:Will it last!
Don't think it even needs to be rumour for the SP jump. RVX didn't really get an expectation bump at all that many companies get when they start COVID trials these days. Mix that in with RVX
...more
(13)
•••
ARR
X
View Profile
View Bullboard History
Comment by
ARR
on Jan 25, 2022 1:27pm
RE:Will it last!
Just wait til end of day when the traders and shorters lower it with small trades.
(3)
•••
seanj1
X
View Profile
View Bullboard History
Comment by
seanj1
on Jan 25, 2022 1:26pm
RE:Will it last!
Well if doctors treating these patients aee the positive results you can be sure it will leak out and fast. I hope they publicize other applications of apabetalone that the company has been working on
...more
(120)
•••
ENEMENEMYNEMO
X
View Profile
View Bullboard History
Post by
ENEMENEMYNEMO
on Jan 25, 2022 12:46pm
Will it last!
Interesting, SP rise must be based on rumor ...there couldn't be any positive results yet, wicked if it was...maybe the doctors and nurses in Alberta are scooping up shares! A way to go for
...more
(3)
•••
seanj1
X
View Profile
View Bullboard History
Post by
seanj1
on Jan 25, 2022 11:49am
Pfizer anti-COVID pill's dangerous interaction
Potential good news for Resverlogix's drug... Pfizer anti-COVID pill's dangerous interaction with common drugs will narrow its benefit, experts say https://vancouversun.com/health/pfizer
...more
(16)
•••
narmac
X
View Profile
View Bullboard History
Post by
narmac
on Jan 25, 2022 10:18am
1,000,000 shorted on RVX and this is all we can muster?
With such a large number of shares on the short side and the newly found enthusiasm for getting the word out on this supposedly soon to know C19 trial data,,one would think the rush for the exit by
...more
(27)
•••
Jkj193741
X
View Profile
View Bullboard History
Comment by
Jkj193741
on Jan 24, 2022 5:35pm
RE:Dr. M. Sweeney interview on CHQR!
AMEN!
(16)
•••
narmac
X
View Profile
View Bullboard History
Post by
narmac
on Jan 24, 2022 12:18pm
Dr. M. Sweeney interview on CHQR!
Somewhat of a waste of time. Too deep for the layperson imo. The Dr. I think has C19 based on his inability to stop a throat cough. Should have taken a rapid test before the studio setting. Too
...more
(16)
•••
narmac
X
View Profile
View Bullboard History
Post by
narmac
on Jan 23, 2022 10:56am
COVID-19 antiviral treatment arrives in Nova Scotia.
Pfizer's Paxlovid will first be offered to the most vulnerable in the province! As for me,,,,no more boosters unless we get a deadly vairiant of C19. Had the three shots in <year and still we
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Do you want to stay ahead of the markets? See how DealRoom can help.
Debt-Free Cannabis Company Set for Next Stage of Growth
Growth Rocket 2025 – Why dynaCERT is in the Spotlight
Learn How this Company is Disrupting Point-of-Care Testing
Why Dozens of Pro Athletes are Paying Attention to this Product